Measuring the impact of pharmacovigilance activities, challenging but important

Drug use is associated with a certain degree of risk. The benefit risk balance is guarded throughout the whole drug life cycle, during the pre-marketing development and testing, as well as after drugs have been approved for use in patients. Drug developers need to comply with rigorous guidelines set by regulatory agencies during the phases of drug development prior to their marketing to prove that these drugs are safe to use in patients.1 But as...